Clinical Trial Update: Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine [Phase 3]

View source ↗

Summary

A Phase 3 trial update for the SARS-CoV-2 rS vaccine sponsored by Cogna Technology Solutions LLC has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syndrome Coronavirus 2

Drugs mentioned

• SARS-CoV-2 rS vaccine

Snippet

Sponsor: Cogna Technology Solutions LLC | Conditions: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Phase 3 | Status: COMPLETED